Le Lézard
Classified in: Health, Science and technology
Subjects: Photo/Multimedia, Product/Service, Recall

Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings


Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels. Markings skewed approximately 20 degrees upward have been identified.

Affected Models and Lot Numbers:

Model
Number

Name

Lot Number

4428-1

Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe 28Gx1/2" 1CC

4046543 and 4062235

4429-1

Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe 29Gx1/2" 1CC

4014096, 4031846, 4031845, 4040734, 4043536, 4046545, 4046546, 4062239, 4062240, 4062238 and 4062242

Please reference the attachment for an illustration of the skewed graduation marking on the syringe barrel.

As a result of this issue, there is potential for administration of an incorrect dose of insulin, which could result in hyperglycemia (which may lead to ketoacidosis) or hypoglycemia (which may lead to seizures). This may result in serious harm or death.

Smiths Medical has received no reports of death or serious injury related to this issue.

Smiths Medical is issuing Recall Notices and Response Forms to consignees of Affected Models and Lot Numbers to instruct them that they must quarantine and return the product.

Additional Information:

This action has been designated as a Class 1 recall by the U.S. Food and Drug Administration (FDA).

Home Healthcare Environments

The lot number can be found on the packaging for the syringe. Do not use any syringes with the affected lot numbers. The patient or caretaker should contact the pharmacy, home healthcare provider or medical facility that provided the syringe to arrange for return of the syringe and replacement.

Smith Medical Contact Information

Consumers with questions regarding this recall may contact Smiths Medical via telephone at 1-(800)-258-5361.

Consumers may also contact Smiths Medical online at https://smiths-medical.custhelp.com.

Specific questions on the recall should be directed to [email protected].

FDA MedWatch Reporting

Adverse reactions or quality problems experienced with the use of these products may also be reported to the FDA's MedWatch Program by:

About Smiths Medical

A leading supplier of specialized medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. For more information, visit www.smiths-medical.com.

About Smiths Group

A global technology company that has been operating for nearly 170 years, delivering products and services for the medical technology, security and defense, general industrial, energy and space and commercial aerospace markets worldwide. Smiths Group plc employs c. 23,000 colleagues in over 50 countries and is listed on the London Stock Exchange. For more information visit www.smiths.com.


These press releases may also interest you

at 15:45
Starting next week, 50Forward and Baylor College of Medicine in Houston, TX will host the All of Us Journey, a traveling educational exhibit that brings the National Institutes of Health's All of Us Research Program to communities across the United...

at 15:36
Starting next week, Network of the National Library of Medicine and SUNY University at Buffalo in Buffalo, NY will host the All of Us Journey, a traveling educational exhibit that brings the National Institutes of Health's All of Us Research Program...

at 15:32
Pinnacle Clinical Research, LLC ("Pinnacle") is deeply saddened by the death of Founder and Chairman Dr. Stephen Harrison. Pinnacle mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones. During an illustrious 30-year...

at 15:30
The International Association of Eating Disorder Professionals (iaedptm) President's Council, after the success of the 2024 Symposium, sets the standards in supporting and advancing the field of eating disorder treatment worldwide. Since its...

at 15:26
An exciting advancement for the specialty pharmacy industry, KEEP announced a strategic partnership with PANTHERx Rare, a leader in rare disease product patient access and support services in the US. This collaboration is set to enhance the...

at 15:12
The Canadian Life and Health Insurance Association (CLHIA) supports the steps announced by the Ontario government yesterday to help family doctors and other primary care providers spend more time with their patients and less time on paperwork. "Our...



News published on and distributed by: